These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33529936)

  • 1. Drug design of new 5-HT
    da Silva AP; Chiari LPA; Guimaraes AR; Honorio KM; da Silva ABF
    J Mol Graph Model; 2021 May; 104():107844. PubMed ID: 33529936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting biological activity and design of 5-HT
    de Sousa DS; da Silva AP; Chiari LPA; de Angelo RM; de Sousa AG; Honorio KM; da Silva ABF
    J Mol Model; 2024 Sep; 30(10):350. PubMed ID: 39325274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease.
    Yahiaoui S; Hamidouche K; Ballandonne C; Davis A; de Oliveira Santos JS; Freret T; Boulouard M; Rochais C; Dallemagne P
    Eur J Med Chem; 2016 Oct; 121():283-293. PubMed ID: 27266998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models.
    Ivachtchenko AV; Ivanenkov YA; Veselov MS; Okun IM
    Curr Alzheimer Res; 2017; 14(3):268-294. PubMed ID: 27829340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exit beyond the pharmacophore model for 5-HT
    Kucwaj-Brysz K; Ali W; Kurczab R; Sudoł-Tałaj S; Wilczyńska-Zawal N; Jastrzębska-Więsek M; Satała G; Mordyl B; Żesławska E; Agnieszka-Olejarz-Maciej ; Czarnota K; Latacz G; Partyka A; Wesołowska A; Nitek W; Handzlik J
    Bioorg Chem; 2022 Apr; 121():105695. PubMed ID: 35228010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and computer-aided SAR studies for derivatives of phenoxyalkyl-1,3,5-triazine as the new potent ligands for serotonin receptors 5-HT
    Ali W; Więcek M; Łażewska D; Kurczab R; Jastrzębska-Więsek M; Satała G; Kucwaj-Brysz K; Lubelska A; Głuch-Lutwin M; Mordyl B; Siwek A; Nasim MJ; Partyka A; Sudoł S; Latacz G; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Eur J Med Chem; 2019 Sep; 178():740-751. PubMed ID: 31229876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are the Hydantoin-1,3,5-triazine 5-HT
    Lubelska A; Latacz G; Jastrzębska-Więsek M; Kotańska M; Kurczab R; Partyka A; Marć MA; Wilczyńska D; Doroz-Płonka A; Łażewska D; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31817628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT6 receptor ligands, EMD386088 and SB258585, differentially regulate 5-HT6 receptor-independent events.
    Yun HM; Rhim H
    Toxicol In Vitro; 2011 Dec; 25(8):2035-40. PubMed ID: 21864673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Pardo L; Schaper K
    J Med Chem; 2001 Jan; 44(2):198-207. PubMed ID: 11170629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.
    Ivachtchenko AV; Okun I; Aladinskiy V; Ivanenkov Y; Koryakova A; Karapetyan R; Mitkin O; Salimov R; Ivashchenko A
    J Alzheimers Dis; 2017; 58(4):1043-1063. PubMed ID: 28550249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer's Disease.
    Grychowska K; Satała G; Kos T; Partyka A; Colacino E; Chaumont-Dubel S; Bantreil X; Wesołowska A; Pawłowski M; Martinez J; Marin P; Subra G; Bojarski AJ; Lamaty F; Popik P; Zajdel P
    ACS Chem Neurosci; 2016 Jul; 7(7):972-83. PubMed ID: 27100049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.
    Benhamú B; Martín-Fontecha M; Vázquez-Villa H; Pardo L; López-Rodríguez ML
    J Med Chem; 2014 Sep; 57(17):7160-81. PubMed ID: 24850589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multitargeting the Action of 5-HT
    Czarnota-Łydka K; Kucwaj-Brysz K; Pyka P; Haberek W; Podlewska S; Handzlik J
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The computer-aided discovery of novel family of the 5-HT
    Łażewska D; Kurczab R; Więcek M; Kamińska K; Satała G; Jastrzębska-Więsek M; Partyka A; Bojarski AJ; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Eur J Med Chem; 2017 Jul; 135():117-124. PubMed ID: 28441580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia.
    de Bruin NM; Kruse CG
    Curr Pharm Des; 2015; 21(26):3739-59. PubMed ID: 26044973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Aminoimidazole-based antagonists of the 5-HT
    Hogendorf AS; Hogendorf A; Kurczab R; Kalinowska-Tłuścik J; Popik P; Nikiforuk A; Krawczyk M; Satała G; Lenda T; Knutelska J; Bugno R; Staroń J; Pietruś W; Matłoka M; Dubiel K; Moszczyński-Pętkowski R; Pieczykolan J; Wieczorek M; Pilarski B; Zajdel P; Bojarski AJ
    Eur J Med Chem; 2019 Oct; 179():1-15. PubMed ID: 31229883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating 5-HT
    Lalut J; Karila D; Dallemagne P; Rochais C
    Future Med Chem; 2017 May; 9(8):781-795. PubMed ID: 28504917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic activation of 5-HT4 receptors or blockade of 5-HT6 receptors improve memory performances.
    Quiedeville A; Boulouard M; Hamidouche K; Da Silva Costa-Aze V; Nee G; Rochais C; Dallemagne P; Fabis F; Freret T; Bouet V
    Behav Brain Res; 2015 Oct; 293():10-7. PubMed ID: 26187692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxytryptamine receptor 6 antagonist, SB258585 exerts neuroprotection in a rat model of Streptozotocin-induced Alzheimer's disease.
    Hashemi-Firouzi N; Shahidi S; Soleimani-Asl S; Komaki A
    Metab Brain Dis; 2018 Aug; 33(4):1243-1253. PubMed ID: 29667108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin 6 receptor controls Alzheimer's disease and depression.
    Yun HM; Park KR; Kim EC; Kim S; Hong JT
    Oncotarget; 2015 Sep; 6(29):26716-28. PubMed ID: 26449188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.